All lobbying filings

Hooper, Lundy & Bookman, P.C.

Hooper, Lundy & Bookman, P.C. filed a Q1 report for Brainfutures on April 18, 2025, reporting $40,000 in lobbying income.

Lobbying for Brainfutures · Nonprofit advocate for therapeutic treatments for mental health and substance use disorder

As filed: HOOPER, LUNDY & BOOKMAN, P.C. for BRAINFUTURES.

All filings by Hooper, Lundy & Bookman, P.C. · Everything Brainfutures has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$40,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Lobbyists on this filing 1

LISA LAYMAN New on this filing

Previously held: SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001- 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to a pathway for FDA approval of psychedelic drugs and therapies, issues related to reducing barriers to research and increasing federal funding of clinical research trials for psychedelic drugs and therapies; Issues related to medical adoption of and access to psychedelic drugs and therapies; S. 331 - HALT Fentanyl Act, provisions related to research.

Medical/Disease Research/Clinical Labs

Bills named in this filing 1

S. 331
HALT Fentanyl Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.